cephalexin

Product NDC
62756-293
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
cephalexin
Dosage form
CAPSULE
Route
ORAL
Labeler
Sun Pharmaceutical Industries Limited
Application
ANDA062791
Marketing category
ANDA
Substance
CEPHALEXIN
Current FDA listing
Historical FDA.report record

Related Records

Packages

No records found.

Related DailyMed Labels

Set IDTitleManufacturerEffective dateTypeVersion
cab0d668-f4a4-4848-ba93-fa2c2246096cCephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.Aidarex Pharmaceuticals LLC2012-09-13HUMAN PRESCRIPTION DRUG LABEL3
87f388c6-c942-47f5-b685-0f7ce0e431f4Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.Rebel Distributors Corp2012-04-18HUMAN PRESCRIPTION DRUG LABEL1
a1f0118a-c13b-4f8b-b77c-a40de5fd1444Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.Unit Dose Services2010-06-14Human Prescription Drug Label4
ec678657-42f1-4a51-a596-129033e2ff60Cephalexin Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, USP and other antibacterial drugs, cephalexin capsule, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.Sun Pharmaceutical Industries Limited2010-06-14Human Prescription Drug Label1